Some patients in a clinical trial of one new drug lost so much weight that they became concerned and dropped out.

Too much of a good thing? Participants taking the highest dose of Eli Lilly’s new GLP-1 drug lost an average of 28.7% of their body weight in a late-stage trial, putting it on track to be a ...

A public health expert explains how GLP-1 drugs have changed the way healthcare providers understand and treat obesity.

The AACE consensus statement emphasizes improvement of overall health in addition to weight reduction among adults with obesity and adiposity-based chronic disease.

Women and those from middle-income backgrounds are predominantly taking up weight loss injections, new research indicates. An ...

Intermittent fasting might be trendy—but the evidence suggests it’s no magic bullet for weight loss. Intermittent fasting may not deliver greater weight loss than standard diet advice or even no ...

New approaches to obesity treatment are emerging as scientists target underexplored metabolic pathways with the help of artificial intelligence. Demand for better obesity medicines is rising quickly, ...

In October of last year, Kailera Therapeutics unveiled a whopping $600 mill | Kailera Therapeutics and its China partner ...

Obesity is not just about appearance; it is a serious medical condition. At Sahitya Aaj Tak Lucknow 2026, leading doctors explained the science behind weight gain and diabetes.

New research shows people with obesity have different mouth bacteria. A simple saliva test may one day help detect obesity risk earlier.

While serious complications from asthma have been on the downswing, the rise of obesity could blunt that progress. Here’s how to help your patients with obesity and asthma.